Article
Efalizumab retreatment works as effectively as original treatmentPhysician: Kim A. Papp, M.D.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Cutibacterium acnes Dominates the Post-Laser Skin Microbiome
Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor
Tralokinumab Eases Joint Pain in Patients with AD
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
Triveni Bio Launches First-in-Human Trial for TRIV-509 in Atopic Dermatitis
AC-201 Shows Strong Phase 2 Results in Psoriasis Trial